These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23645386)

  • 1. Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.
    Marchiani A; Mammi S; Siligardi G; Hussain R; Tessari I; Bubacco L; Delogu G; Fabbri D; Dettori MA; Sanna D; Dedola S; Serra PA; Ruzza P
    Amino Acids; 2013 Aug; 45(2):327-38. PubMed ID: 23645386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol.
    Esatbeyoglu T; Ulbrich K; Rehberg C; Rohn S; Rimbach G
    Food Funct; 2015 Mar; 6(3):887-93. PubMed ID: 25619943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells.
    Ishido M
    J Pineal Res; 2007 Mar; 42(2):125-30. PubMed ID: 17286743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin inhibits aggregation of alpha-synuclein.
    Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
    Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
    Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
    Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of quinoline derivatives of tetrahydrocurcumin and zingerone and evaluation of their antioxidant and antibacterial attributes.
    Manjunatha JR; Bettadaiah BK; Negi PS; Srinivas P
    Food Chem; 2013 Jan; 136(2):650-8. PubMed ID: 23122110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
    Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity.
    Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK
    Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
    Ono K; Yamada M
    J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions of alpha-synuclein with Congo red and lacmoid.
    Lendel C; Bertoncini CW; Cremades N; Waudby CA; Vendruscolo M; Dobson CM; Schenk D; Christodoulou J; Toth G
    Biochemistry; 2009 Sep; 48(35):8322-34. PubMed ID: 19645507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives.
    Fang L; Gou S; Liu X; Cao F; Cheng L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):40-3. PubMed ID: 24342238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fibrillation process of alpha-synuclein at the initial stage.
    Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S
    Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer.
    Xu J; Wei C; Xu C; Bennett MC; Zhang G; Li F; Tao E
    Brain Res; 2007 Mar; 1139():220-5. PubMed ID: 17280646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
    Verhaar R; Jongenelen CA; Gerard M; Baekelandt V; Van Dam AM; Wilhelmus MM; Drukarch B
    Neurochem Int; 2011 Jun; 58(7):785-93. PubMed ID: 21440023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised calcium promotes α-synuclein aggregate formation.
    Nath S; Goodwin J; Engelborghs Y; Pountney DL
    Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
    Kim S; Seo JH; Suh YH
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells.
    Fan GH; Zhou HY; Yang H; Chen SD
    FEBS Lett; 2006 May; 580(13):3091-8. PubMed ID: 16678164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.
    Li J; Zhu M; Manning-Bog AB; Di Monte DA; Fink AL
    FASEB J; 2004 Jun; 18(9):962-4. PubMed ID: 15059976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.